WNTinib | MedChemExpress (MCE)
WNTinib (APS-8-100-2) is a multi-kinase inhibitor that selectively antagonizes β-catenin (CTNNB1) mutated hepatocellular carcinoma (HCC). WNTinib downregulates oncogenicWntsignaling by inhibiting KIT/MAPK and downstream EZH2 activation[1].
| Trivial name | WNTinib |
| Catalog Number | HY-160765 |
| Alternative Name(s) | APS-8-100-2 |
| Research Area | Cancer |
| CAS# | 2770091-44-4 |
| Purity | ≥98.0% |
| SMILES | O=C(NC1=CC=C(C=C1F)OC2=CC(C(NC)=O)=NC=C2)NC3=CC=C(C(F)(C(F)(F)F)F)C=C3 |
| Size | 1 mg |
| Supplier Page | https://www.medchemexpress.com/wntinib.html |